GPT and fatty liver disease: The mechanism of naltrexone treatment for steatosis is not clear, but the results of this study showed that compared with group B, after treatment with naltrexone in group C, the bodyweight, fat mass, fat index, ALT, and TG decreased significantly and the degree of hepatic steatosis decreased (P < 0.05).